Roche to present significant progress in advanced skin, lung and ovarian cancers at ASCO
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Shire to establish new Regenerative Medicine business unit through cash acquisition of Advanced BioHealing, Inc.
- Details
- Category: Shire
![Shire Shire](/images/stories/logo/shire.gif)
Pfizer To Present New Research From Fifteen Compounds
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Patrick Dempsey Teams up With Breakaway from Cancer(R)
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
New drug applications submitted in the United States and Europe for vemurafenib in advanced skin cancer
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Pharmaceutical industry and university create Manchester Collaborative Centre for Inflammation Research
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
More Pharma News ...
- Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment versus generic Clopidogrel
- Sanofi-aventis and Medicines for Malaria Venture Join Forces to Develop Innovative Malaria Drugs
- Novartis gains FDA approval for Afinitor®
- FDA approves linagliptin tablets for the treatment of type 2 diabetes
- Pfizer Reports First-Quarter 2011 Results
- Bayer off to a successful start to 2011
- Pfizer Announces Top-Line Results of Final Two Pivotal Phase 3 Trials of Tofacitinib (CP-690,550)